The Manufacturers Life Insurance Company Takes Position in Ralliant Corporation $RAL

The Manufacturers Life Insurance Company bought a new position in shares of Ralliant Corporation (NYSE:RAL - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 99,840 shares of the company's stock, valued at approximately $7,351,000. The Manufacturers Life Insurance Company owned approximately 0.09% of Ralliant at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. bought a new position in shares of Ralliant during the second quarter valued at approximately $1,039,481,000. Viking Global Investors LP purchased a new stake in Ralliant during the second quarter worth $257,200,000. State Street Corp purchased a new stake in Ralliant during the second quarter worth $213,096,000. Millennium Management LLC boosted its position in Ralliant by 172.4% during the 4th quarter. Millennium Management LLC now owns 4,973,001 shares of the company's stock valued at $253,175,000 after acquiring an additional 3,147,660 shares in the last quarter. Finally, Flossbach Von Storch SE purchased a new position in shares of Ralliant in the 2nd quarter valued at $222,460,000.

Insider Buying and Selling at Ralliant

In related news, SVP Karen M. Bick sold 6,062 shares of the firm's stock in a transaction on Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the completion of the transaction, the senior vice president owned 31,668 shares in the company, valued at $2,280,096. This trade represents a 16.07% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of Ralliant stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer directly owned 251,967 shares of the company's stock, valued at approximately $18,088,710.93. This represents a 4.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by corporate insiders.

Ralliant Trading Down 0.1%

Ralliant stock opened at $61.65 on Monday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. The stock has a market cap of $6.82 billion, a PE ratio of -5.68, a price-to-earnings-growth ratio of 2.29 and a beta of 1.61. The stock has a 50-day moving average of $68.40 and a two-hundred day moving average of $56.53. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41.

Ralliant (NYSE:RAL - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, topping analysts' consensus estimates of $0.63 by $0.05. The business had revenue of $567.80 million for the quarter. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, research analysts anticipate that Ralliant Corporation will post 2.87 EPS for the current fiscal year.

Ralliant Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. Ralliant's payout ratio is -1.84%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on RAL. Oppenheimer upped their price objective on Ralliant from $50.00 to $65.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 13th. Truist Financial reiterated a "buy" rating and issued a $82.00 target price (up from $68.00) on shares of Ralliant in a report on Friday, July 31st. Citigroup increased their price target on shares of Ralliant from $81.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, July 31st. TD Cowen raised their price target on shares of Ralliant from $70.00 to $80.00 and gave the company a "buy" rating in a report on Friday, July 31st. Finally, Evercore assumed coverage on shares of Ralliant in a report on Tuesday, June 9th. They issued an "outperform" rating and a $80.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Ralliant currently has an average rating of "Moderate Buy" and an average price target of $75.70.

Ralliant Company Profile

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source